Categories for Client News
Cancer Death Rates Continue to Decline in the United States, ACS Reports
The death rate from cancer in the U.S. dropped 2.4% from 2017 to 2018, the biggest single-year decline on record and a sign of the impact of new treatments on lung cancer especially, the American Cancer Society said.
$80 Million for Childhood Cancer Research Signed into Law
Congress passed a federal funding bill that included $80 million specially set aside for childhood cancer research programs.
Lupus Research Alliance Recognizes Winners of 2020 Lupus Innovation Award
The Lupus Research Alliance has announced the 2020 Lupus Innovation Award recipients. These seven recipients are tackling projects that represent a wide breadth of scientific exploration of the disease.
The ALS Association Selects ProposalCentral to Scale its Grant Making Efforts
To intelligently scale its grant-making efforts, The ALS Association selected Altum’s ProposalCentral for its ease-of-use and comprehensive capabilities.
FDA to Review Promising New Alzheimer’s Treatment on November 6, 2020
On November 6, the Food and Drug Administration is convening a meeting of outside experts to review the data from two Phase 3 clinical trials of a new drug developed for treating cognitive and functional decline in early Alzheimer’s disease
Lupus Research Alliance Findings Support Further Development of New Treatments
The Lupus Research Alliance, a Proposal Central customer, recently published findings that support further development by several companies of potential new lupus treatments.
ALS Foundation Petitions FDA to Make Treatment Available ASAP
An exciting and promising breakthrough for the treatment of ALS is now in clinical trials. The ALS Foundation and I AM ALS have petitioned the FDA to make the treatment available as soon as possible.